January 2025
·
15 Reads
e m b e r 2 0 2 4 , V o l. 5 , N o. 2 P a g e 18 | 9 ABSTRACT Objective: This study sought to compare the hemodynamic responses to laryngoscopy and tracheal intubation between Nalbuphine and Midazolam to assess their efficacy and safety in clinical practice. Study Design: Randomized Control Trial Place and Duration of the Study: Department of Anesthesia at Faculty of Allied Health Sciences, Superior University, Lahore and duration of the study was six months from jan 2024 to june 2024 Materials and Methods: A randomized controlled experiment Trial was performed at Department of Anesthesia Faculty of Allied Health Sciences involving 168 people, evenly split into two groups: Group N (Nalbuphine, n=84) and Group M (Midazolam, n=84). The inclusion criteria were patients aged 20 to 60 years, classified as ASA I or II, who were scheduled for laparoscopic cholecystectomy. Participants received either Nalbuphine or Midazolam preoperatively, and hemodynamic parameters (heart rate, systolic and diastolic blood pressure, mean arterial pressure, and SPO₂) were assessed at baseline and at 2, 4, 6, 8, and 10 minutes following intubation. Statistical analyses encompassed t-tests for group comparisons and regression analysis to ascertain drivers of mean arterial pressure. Results: The trial comprised 168 subjects, equally allocated to Group N (Nalbuphine) and Group M (Midazolam), with no statistically significant differences in demographic factors including age (p = 0.482), gender (p = 0.742), weight (p = 0.632), or surgical time (p = 0.601). Initially, hemodynamic parameters were comparable; however, post-induction, substantial differences emerged, with Group N demonstrating reduced heart rate (p = 0.001), systolic blood pressure (p = 0.000), diastolic blood pressure (p = 0.000), and mean arterial pressure (p = 0.000) at all time points. Regression analysis revealed significant predictors of mean arterial pressure (MAP), including heart rate (β = 0.45, p = 0.000), systolic blood pressure (BP) (β = 0.32, p = 0.001), and diastolic BP (β = 0.56, p = 0.000). Conversely, group membership exhibited a significant negative correlation (β =-5.25, p = 0.000), indicating a preference for Nalbuphine in achieving enhanced hemodynamic stability. Conclusion: The study determined that Nalbuphine offered superior hemodynamic stability relative to Midazolam during laryngoscopy and tracheal intubation in laparoscopic cholecystectomy. Nalbuphine was correlated with markedly reduced heart rate, blood pressure, and mean arterial pressure at all measured intervals. Comparative study of Nalbuphine verses Midazolam on hemodynamic response ....... J B K M C , J u l y-D e c e m b e r 2 0 2 4 , V o l. 5 , N o. 2 P a g e 19 | 9